Skip to main content
NIH funding notice PAR-19-279

Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional)

Closed on November 15, 2020.

Posted
May 13, 2019
Close date
November 15, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,666,149 in first-year total cost, median $739,531.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 OBT-B (55)]6

Most frequent institutions

  1. BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
  2. BOSTON UNIVERSITY MEDICAL CAMPUS1
  3. NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
  4. UNIVERSITY OF ALABAMA AT BIRMINGHAM1
  5. UNIVERSITY OF CALIFORNIA-IRVINE1
Competing awards under PAR-19-279 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Mutographs differentiating the racial and temporal incidence of multiple myeloma1R01CA249981-01A1MORGAN, GARETH JOHNNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$1,234,790ZRG1
2021Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts1R01CA260615-01BERTRAND, KIMBERLY A.COZEN, WENDYDESAI, PINKALUNIVERSITY OF CALIFORNIA-IRVINE, CA$975,742ZRG1
2021Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities1R01CA249982-01A1BERTRAND, KIMBERLY A.WANG, SOPHIA S.BOSTON UNIVERSITY MEDICAL CAMPUS, MA$760,146ZRG1
2021Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans1R01CA253545-01A1PICHIORRI, FLAVIAROSEN, STEVEN TERRYROSENZWEIG, MICHAELBECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA$718,916ZRG1
2021Epigenetic contribution to the excess risk of MGUS in African Americans1U01CA249955-01A1BROWN, ELIZABETH EUNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$616,274ZRG1
2020Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective1R01CA253475-01CHANG, SU-HSINWASHINGTON UNIVERSITY, MO$360,281ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-279: Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) | ScienceDex | ConductScience